NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0640
-0.0010 (-1.54%)
Aug 26, 2026, 1:01 PM AEST

ASX:NSB Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-4.69-1.850.32-1.07-10.44
Depreciation & Amortization
1.380.090.090.060.06
Asset Writedown & Restructuring Costs
0.21----
Stock-Based Compensation
0.420.80.130.241.35
Other Operating Activities
-0.17----
Change in Accounts Receivable
-0.03-0.04-0.010.08-0.07
Change in Accounts Payable
0.090.05-0.5-1.581.99
Change in Other Net Operating Assets
0.0100.01-0.030.16
Operating Cash Flow
-2.78-0.940.04-2.3-6.94
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
---0--0
Cash Acquisitions
--0.04---
Investment in Securities
-2----
Other Investing Activities
0.17----
Investing Cash Flow
-1.83-0.04-0--0

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Long-Term Debt Repaid
-0.01----
Net Debt Issued (Repaid)
-0.01----
Issuance of Common Stock
-3.5---
Other Financing Activities
-0.02-0.21---
Financing Cash Flow
-0.033.29---

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash Flow
-4.642.310.04-2.3-6.95

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-2.78-0.940.04-2.3-6.95
Free Cash Flow Growth
-----
Free Cash Flow Margin
-441.39%-1.92%-46.52%-
Free Cash Flow Per Share
-0.01-0.01--0.02-0.05
Levered Free Cash Flow
-0.9-0.34-0.19-1.97-3.08
Unlevered Free Cash Flow
-0.89-0.34-0.18-1.97-3.08

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Change in Working Capital
0.070.01-0.5-1.542.08